Autoantibodies and Systemic Lupus Erythematosus in a Moroccan Population

  title={Autoantibodies and Systemic Lupus Erythematosus in a Moroccan Population},
  author={R. Hazime and M. Rami and Ikram Brahim and L. Elmoumou and Brahim Admou},
Original Research Article Introduction: Systemic lupus erythematosus is characterized by various autoantibodies which prevalence and clinical significance vary among populations. The aim of our research is to study the immunological profile of autoantibodies in Moroccan population with lupus. Patients and methods: Seventy-seven patients with lupus meeting at least four criteria of the 1997 ACR had an ANA screening by indirect immunofluorescence method (IIF) on HEp-2 substrate (Kallstad, Biorad… Expand


Autoanticorps dans le lupus rythmateux systmique : profil et corrlations cliniques
  • 12
  • Highly Influential
[Evolution of autoantibodies profile in systemic lupus erythematosus according to age and clinical manifestations].
  • 7
  • Highly Influential
  • PDF
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.
  • 8,639
  • Highly Influential
  • PDF
Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1000 patients
  • The EuropeanWorking Party on systemic lupus erythematosus. Medicine
  • 1993
X.Clinical and serologic correlations and autoantibody clusters in systemic lupus erythematosus: A retrospective review of 917 patients
  • in South China. Medicine
  • 2010
Autoantibodies in black South Africans with systemic lupus erythematosus: Spectrum and clinical associations
  • 57
  • Highly Influential
Caractéristiques cliniques et sérologiques du lupus érythémateux systémique: à propos de 128 cas.Pathol Biol
  • 2002
Diagnostic association in large and consecutively identified population for anti-SSA and/or anti-SSB: the range of associated diseases differs according to Hazime R et al., Sch
  • J App Med Sci,
  • 2020
Lupus systémique et atteinte rénale: apport des anticorps anti-SSA
  • 2
  • PDF